EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY 4.0

Myosteatosis and the clinical outcomes of patients with liver cirrhosis: A meta-analysis

Haojie Xue, Yihan Liu, Yang Liu, Han Li, Qian Liang, Longhui Ma, Junying Liu iD, Ming Zhao

PLOS ONE · 12.09.2024 · 19 (9) · e0310017

DOI: 10.1371/journal.pone.0310017 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift PLOS ONE, online erschienen am 12.09.2024. Verfasst von Haojie Xue und 7 weiteren Autor:innen. Beteiligte Einrichtung: Zhoukou Central Hospital Affiliated to Xinxiang Medical University, Zhoukou City, Henan Province, China. Hauptthemen laut MEDLINE: Liver Cirrhosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study aimed to examine the potential correlation between myosteatosis and the prognosis of patients diagnosed with liver cirrhosis by a meta-analysis.

Methods

Cohort studies of relevance were acquired through comprehensive searches of the Medline, Web of Science, and Embase databases. To account for heterogeneity, a random-effects model was employed to combine the findings.

Results

The meta-analysis included 10 retrospective and four prospective cohort studies, encompassing a total of 4287 patients diagnosed with cirrhosis. The pooled findings indicated a notable decline in transplant-free survival (TFS) among individuals with liver cirrhosis and myosteatosis compared to those without this condition (risk ratio: 1.94; 95% confidence interval: 1.61 to 2.34, p < 0.001; I 2 = 49%). The predefined subgroup analyses demonstrated consistent findings across various categories, including Asian and non-Asian studies, prospective and retrospective cohort studies, patients with cirrhosis overall and those who underwent transjugular intrahepatic portosystemic shunt, studies with different follow-up durations (< or ≥ 24 months), studies employing univariate and multivariate analyses, and studies with and without an adjustment for sarcopenia ( p > 0.05 for all subgroup differences). Additionally, Egger’s regression test indicated the presence of significant publication bias ( p = 0.044). However, trim-and-fill analysis by including three hypothesized studies showed consistent results.

Conclusions

The presence of myosteatosis in individuals diagnosed with liver cirrhosis may potentially be linked to a poor TFS prognosis. Further investigations are required to ascertain whether enhancing myosteatosis could potentially yield a survival advantage for this particular patient population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver CirrhosisHumansPortasystemic Shunt, Transjugular IntrahepaticPrognosisRetrospective StudiesSarcopenia

Autor:innen und Institutionen

  • Zhoukou Central Hospital Affiliated to Xinxiang Medical University, Zhoukou City, Henan Province, China.
  • Ward 1, Department of Gastroenterology, Zhoukou Central Hospital, Zhoukou City, Henan Province, China.
  • Zhoukou Central Hospital, Zhoukou City, Henan Province, China.

ORCID-Profile: Junying Liu

Zitieren

APA

Xue, H., Liu, Y., Liu, Y., Li, H., Liang, Q., Ma, L., Liu, J., & Zhao, M. (2024). Myosteatosis and the clinical outcomes of patients with liver cirrhosis: A meta-analysis. PLOS ONE, 19(9), e0310017. https://doi.org/10.1371/journal.pone.0310017

Vancouver

Xue H, Liu Y, Liu Y, Li H, Liang Q, Ma L, et al. Myosteatosis and the clinical outcomes of patients with liver cirrhosis: A meta-analysis. PLOS ONE. 2024;19(9):e0310017. doi:10.1371/journal.pone.0310017

BibTeX
@article{Xue2024,
  author = {Xue, Haojie and Liu, Yihan and Liu, Yang and Li, Han and Liang, Qian and Ma, Longhui and Liu, Junying and Zhao, Ming},
  title = {Myosteatosis and the clinical outcomes of patients with liver cirrhosis: A meta-analysis},
  journal = {PLOS ONE},
  year = {2024},
  volume = {19},
  number = {9},
  pages = {e0310017},
  doi = {10.1371/journal.pone.0310017}
}
Kostenlos starten →